Stryker’s Organic Orthopedic Revenue Declines Slightly in 1Q21

Stryker's logo

Stryker reported 1Q21 orthopedic revenue of USD $2,068.5 million, +15.3% vs. 1Q20. The company’s organic orthopedic revenue declined low single digits for the quarter, with international growth partially offsetting U.S. losses. Stryker’s trauma and extremities business, inclusive of Wright Medical, grew +2.6% on a comparable basis led by...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us